Prudential Financial’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$550K Buy
21,970
+9,215
+72% +$218K ﹤0.01% 1825
2025
Q4
$336K Sell
12,755
-20,635
-62% -$450K ﹤0.01% 1945
2025
Q3
$570K Sell
33,390
-11,575
-26% -$166K ﹤0.01% 1885
2025
Q2
$564K Buy
44,965
+2,395
+6% +$28.5K ﹤0.01% 1901
2025
Q1
$507K Buy
42,570
+22,910
+117% +$312K ﹤0.01% 1833
2024
Q4
$288K Buy
+19,660
New +$275K ﹤0.01% 1996
2024
Q3
Sell
-43,160
Closed -$367K 2808
2024
Q2
$367K Buy
43,160
+2,900
+7% +$25.8K ﹤0.01% 2297
2024
Q1
$424K Sell
40,260
-196,000
-83% -$2.18M ﹤0.01% 2225
2023
Q4
$2.45M Buy
236,260
+15,550
+7% +$124K ﹤0.01% 1308
2023
Q3
$1.4M Buy
220,710
+195,900
+790% +$1.45M ﹤0.01% 1589
2023
Q2
$214K Buy
+24,810
New +$222K ﹤0.01% 2416

Other funds holding ZYME

Prudential Financial's ZYME Position: Q1 2026 in Review

Prudential Financial increased its Zymeworks (ZYME) stake by 72% in Q1 2026, buying an estimated $218K and bringing the position to 21,970 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #1825.

Prudential Financial first reported a position in ZYME in Q2 2023 and has held it in 11 quarters since. The position peaked at $2.45M in Q4 2023. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Prudential Financial held 21,970 shares of Zymeworks worth $550K as of Q1 2026.
  • Prudential Financial bought 9,215 Zymeworks shares in Q1 2026, an estimated $218K.
  • Zymeworks made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #1825 holding.
  • Prudential Financial first reported a position in Zymeworks in Q2 2023 and has held it in 11 quarters since.
  • Prudential Financial's Zymeworks position peaked at $2.45M in Q4 2023.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.